Stocks Health care IART
NASDAQ · Health careIntegra Lifesciences Holdings Corp (IART)
Integra Lifesciences Holdings Corp brought in $1.6B of revenue over the twelve months to June 30, 2026, up 1.6% from a year earlier. It posted a net loss of $7.2M. In fiscal 2025 capital spending exceeded operating cash flow by $31.1M. At June 30, 2026 it held $214.4M in cash against $707.2M of debt. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on July 29, 2026.
What Integra Lifesciences Holdings Corp does
Integra Lifesciences Holdings Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker IART.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $1.6B | -$516.5M | -$6.74 | -$31.1M |
| 2024 | $1.6B | -$6.9M | -$0.09 | $25M |
| 2023 | $1.5B | $67.7M | $0.84 | $73.1M |
| 2022 | $1.6B | $180.6M | $2.16 | $222.1M |
| 2021 | $1.5B | $169.1M | $1.98 | $264.4M |
| 2020 | $1.4B | $133.9M | $1.57 | $164.9M |
Latest SEC filings
What Integra Lifesciences Holdings Corp has filed recently, newest first. Each links to the original document on SEC EDGAR.
- September 8, 2026
- August 13, 2026Passive stake changed SCHEDULE 13G/A
- July 31, 2026Passive stake (5% or more) SCHEDULE 13G
- July 29, 2026Quarterly report 10-Q · period to June 30, 2026
- July 29, 2026
- May 29, 2026
- May 15, 2026Passive stake (5% or more) SCHEDULE 13G
- May 8, 2026
- May 8, 2026
- May 5, 2026Quarterly report 10-Q · period to March 31, 2026
Questions about IART
What does Integra Lifesciences Holdings Corp do?
Integra Lifesciences Holdings Corp is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker IART.
Is Integra Lifesciences Holdings Corp profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $7.2M on revenue of $1.6B.
How much revenue does Integra Lifesciences Holdings Corp make?
Over the twelve months to June 30, 2026 Integra Lifesciences Holdings Corp reported revenue of $1.6B. That is 1.6% more than a year earlier.
When did Integra Lifesciences Holdings Corp last report?
Its most recent periodic report is the quarterly report (10-Q) filed on July 29, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from September 8, 2026.
Similar companies
Follow IART
Get an email when Integra Lifesciences Holdings Corp files with the SEC: results, executive changes, material agreements and annual reports.
Follow IART: get an email when it filesWhere the numbers come from
Financial figures are the values Integra Lifesciences Holdings Corp tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.